Correction to: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy (Oncogene, (2015), 34, 15, (1919-1927), 10.1038/onc.2014.138)

D. Elias*, H. Vever, A. V. Lænkholm, M. F. Gjerstorff, C. W. Yde, A. E. Lykkesfeldt, H. J. Ditzel

*Corresponding author for this work

Research output: Contribution to journalComment/debateResearchpeer-review

115 Downloads (Pure)

Abstract

Since the online publication of the above article, the authors have noted errors in subfigures 1c and 3b. Therefore, new images of the original immmunocytochemistry stainings have been obtained for Fig. 1c, and the Western blots for siRNA-mediated FYN knockdown in Fig. 3b were repeated. The amended versions of Figs. 1c and 3b are now provided.

Original languageEnglish
JournalOncogene
Volume37
Issue number41
Pages (from-to)5585–5586
ISSN0950-9232
DOIs
Publication statusPublished - Oct 2018

Fingerprint

Dive into the research topics of 'Correction to: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy (Oncogene, (2015), 34, 15, (1919-1927), 10.1038/onc.2014.138)'. Together they form a unique fingerprint.

Cite this